TwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedN
NFX
Activity from announced rounds
Activity in this selectionUnited States · Oct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 1 First participation on record · 1 follow-on
- Funding in participating rounds
- $312.5M 2 disclosed · full round size, not this investor’s share